Cardioprotective Effects of a Novel Hydrogen Sulfide Agent–Controlled Release Formulation of S-Propargyl-Cysteine on Heart Failure Rats and Molecular Mechanisms

OBJECTIVE: Heart failure (HF) is one of the most serious diseases worldwide. S-propargyl-cysteine (SPRC), a novel modulator of endogenous hydrogen sulfide, is proved to be able to protect against acute myocardial ischemia. In order to produce more stable and sustainable hydrogen sulfide, we used con...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chengrong, Kan, Juntao, Liu, Xu, Ma, Fenfen, Tran, Ba Hieu, Zou, Yunzeng, Wang, Shujun, Zhu, Yi Zhun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706411/
https://www.ncbi.nlm.nih.gov/pubmed/23874913
http://dx.doi.org/10.1371/journal.pone.0069205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706411/
https://www.ncbi.nlm.nih.gov/pubmed/23874913
http://dx.doi.org/10.1371/journal.pone.0069205

Ejemplares similares